Use of bromazepam in obsessional, phobic and related states
Summary Two hundred and twenty patients with nervous conditions in which obsessionality was a prominent underlying cause were treated with a new benzodiazepine compound, bromazepam. Patients had previously been treated using other benzodiazepine compounds with unsatisfactory results. The majority im...
Gespeichert in:
| Veröffentlicht in: | Current medical research and opinion 1974, Vol.2 (7), p.430-436 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 436 |
|---|---|
| container_issue | 7 |
| container_start_page | 430 |
| container_title | Current medical research and opinion |
| container_volume | 2 |
| creator | Burrell, R. H. Culpan, R. H. Newton, K. J. Ogg, G. J. Short, J. H. W. |
| description | Summary
Two hundred and twenty patients with nervous conditions in which obsessionality was a prominent underlying cause were treated with a new benzodiazepine compound, bromazepam. Patients had previously been treated using other benzodiazepine compounds with unsatisfactory results. The majority improved significantly and maintained their improvement while bromazepam was continued. |
| doi_str_mv | 10.1185/03007997409112660 |
| format | Article |
| fullrecord | <record><control><sourceid>informahealthcare_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1185_03007997409112660</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1185_03007997409112660</sourcerecordid><originalsourceid>FETCH-LOGICAL-c401t-609f831f34fd5836acaa64bb7bc1c9260b7d1d0f2b20b42d632a806e57b54ce83</originalsourceid><addsrcrecordid>eNp9kM1Kw0AUhQdRaq0-gAshD2D0TmYyk1A3UvyDghu7Dnf-aEqSCTMpok9vSosgQldnce53OPcQck3hjtIivwcGIMtScigpzYSAEzKlXLKUF1KekunOT8eD_JxcxLgBoFlRlhMy4TQXAHxK5qtoE-8SFXyL37bHNqm7xKtoY6x9h81t0q-9qnWCnUmCbXCwJonDKPGSnDlsor066Iysnp8-Fq_p8v3lbfG4TDUHOqQCSlcw6hh3Ji-YQI0ouFJSaarLTICShhpwmcpA8cwIlmEBwuZS5Vzbgs0I3efq4GMM1lV9qFsMXxWFardD9W-HkbnZM_1Wtdb8EofHR_9h79ed86HFTx8aUw341fjgAna6jhU7Fj__g68tNsNaY7DVxm_DuFs8Uu4HjTB8vw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Use of bromazepam in obsessional, phobic and related states</title><source>MEDLINE</source><source>Taylor & Francis Medical Library - CRKN</source><source>Access via Taylor & Francis</source><creator>Burrell, R. H. ; Culpan, R. H. ; Newton, K. J. ; Ogg, G. J. ; Short, J. H. W.</creator><creatorcontrib>Burrell, R. H. ; Culpan, R. H. ; Newton, K. J. ; Ogg, G. J. ; Short, J. H. W.</creatorcontrib><description>Summary
Two hundred and twenty patients with nervous conditions in which obsessionality was a prominent underlying cause were treated with a new benzodiazepine compound, bromazepam. Patients had previously been treated using other benzodiazepine compounds with unsatisfactory results. The majority improved significantly and maintained their improvement while bromazepam was continued.</description><identifier>ISSN: 0300-7995</identifier><identifier>EISSN: 1473-4877</identifier><identifier>DOI: 10.1185/03007997409112660</identifier><identifier>PMID: 4156004</identifier><language>eng</language><publisher>England: Informa UK Ltd</publisher><subject>Adult ; Anti-Anxiety Agents - adverse effects ; Anti-Anxiety Agents - therapeutic use ; Benzodiazepines ; Bromazepam ; compulsive ; Female ; Humans ; Male ; Middle Aged ; neurosis, obsessive ; Obsessive-Compulsive Disorder - drug therapy ; phobias ; Phobic Disorders - drug therapy ; Pyridines - adverse effects ; Pyridines - therapeutic use ; Substance Withdrawal Syndrome ; tranquillizing agents</subject><ispartof>Current medical research and opinion, 1974, Vol.2 (7), p.430-436</ispartof><rights>1974 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1974</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c401t-609f831f34fd5836acaa64bb7bc1c9260b7d1d0f2b20b42d632a806e57b54ce83</citedby><cites>FETCH-LOGICAL-c401t-609f831f34fd5836acaa64bb7bc1c9260b7d1d0f2b20b42d632a806e57b54ce83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1185/03007997409112660$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1185/03007997409112660$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>314,780,784,4024,27923,27924,27925,59647,59753,60436,60542,61221,61256,61402,61437</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/4156004$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Burrell, R. H.</creatorcontrib><creatorcontrib>Culpan, R. H.</creatorcontrib><creatorcontrib>Newton, K. J.</creatorcontrib><creatorcontrib>Ogg, G. J.</creatorcontrib><creatorcontrib>Short, J. H. W.</creatorcontrib><title>Use of bromazepam in obsessional, phobic and related states</title><title>Current medical research and opinion</title><addtitle>Curr Med Res Opin</addtitle><description>Summary
Two hundred and twenty patients with nervous conditions in which obsessionality was a prominent underlying cause were treated with a new benzodiazepine compound, bromazepam. Patients had previously been treated using other benzodiazepine compounds with unsatisfactory results. The majority improved significantly and maintained their improvement while bromazepam was continued.</description><subject>Adult</subject><subject>Anti-Anxiety Agents - adverse effects</subject><subject>Anti-Anxiety Agents - therapeutic use</subject><subject>Benzodiazepines</subject><subject>Bromazepam</subject><subject>compulsive</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>neurosis, obsessive</subject><subject>Obsessive-Compulsive Disorder - drug therapy</subject><subject>phobias</subject><subject>Phobic Disorders - drug therapy</subject><subject>Pyridines - adverse effects</subject><subject>Pyridines - therapeutic use</subject><subject>Substance Withdrawal Syndrome</subject><subject>tranquillizing agents</subject><issn>0300-7995</issn><issn>1473-4877</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1974</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1Kw0AUhQdRaq0-gAshD2D0TmYyk1A3UvyDghu7Dnf-aEqSCTMpok9vSosgQldnce53OPcQck3hjtIivwcGIMtScigpzYSAEzKlXLKUF1KekunOT8eD_JxcxLgBoFlRlhMy4TQXAHxK5qtoE-8SFXyL37bHNqm7xKtoY6x9h81t0q-9qnWCnUmCbXCwJonDKPGSnDlsor066Iysnp8-Fq_p8v3lbfG4TDUHOqQCSlcw6hh3Ji-YQI0ouFJSaarLTICShhpwmcpA8cwIlmEBwuZS5Vzbgs0I3efq4GMM1lV9qFsMXxWFardD9W-HkbnZM_1Wtdb8EofHR_9h79ed86HFTx8aUw341fjgAna6jhU7Fj__g68tNsNaY7DVxm_DuFs8Uu4HjTB8vw</recordid><startdate>1974</startdate><enddate>1974</enddate><creator>Burrell, R. H.</creator><creator>Culpan, R. H.</creator><creator>Newton, K. J.</creator><creator>Ogg, G. J.</creator><creator>Short, J. H. W.</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>1974</creationdate><title>Use of bromazepam in obsessional, phobic and related states</title><author>Burrell, R. H. ; Culpan, R. H. ; Newton, K. J. ; Ogg, G. J. ; Short, J. H. W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c401t-609f831f34fd5836acaa64bb7bc1c9260b7d1d0f2b20b42d632a806e57b54ce83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1974</creationdate><topic>Adult</topic><topic>Anti-Anxiety Agents - adverse effects</topic><topic>Anti-Anxiety Agents - therapeutic use</topic><topic>Benzodiazepines</topic><topic>Bromazepam</topic><topic>compulsive</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>neurosis, obsessive</topic><topic>Obsessive-Compulsive Disorder - drug therapy</topic><topic>phobias</topic><topic>Phobic Disorders - drug therapy</topic><topic>Pyridines - adverse effects</topic><topic>Pyridines - therapeutic use</topic><topic>Substance Withdrawal Syndrome</topic><topic>tranquillizing agents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Burrell, R. H.</creatorcontrib><creatorcontrib>Culpan, R. H.</creatorcontrib><creatorcontrib>Newton, K. J.</creatorcontrib><creatorcontrib>Ogg, G. J.</creatorcontrib><creatorcontrib>Short, J. H. W.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Current medical research and opinion</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burrell, R. H.</au><au>Culpan, R. H.</au><au>Newton, K. J.</au><au>Ogg, G. J.</au><au>Short, J. H. W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of bromazepam in obsessional, phobic and related states</atitle><jtitle>Current medical research and opinion</jtitle><addtitle>Curr Med Res Opin</addtitle><date>1974</date><risdate>1974</risdate><volume>2</volume><issue>7</issue><spage>430</spage><epage>436</epage><pages>430-436</pages><issn>0300-7995</issn><eissn>1473-4877</eissn><abstract>Summary
Two hundred and twenty patients with nervous conditions in which obsessionality was a prominent underlying cause were treated with a new benzodiazepine compound, bromazepam. Patients had previously been treated using other benzodiazepine compounds with unsatisfactory results. The majority improved significantly and maintained their improvement while bromazepam was continued.</abstract><cop>England</cop><pub>Informa UK Ltd</pub><pmid>4156004</pmid><doi>10.1185/03007997409112660</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0300-7995 |
| ispartof | Current medical research and opinion, 1974, Vol.2 (7), p.430-436 |
| issn | 0300-7995 1473-4877 |
| language | eng |
| recordid | cdi_crossref_primary_10_1185_03007997409112660 |
| source | MEDLINE; Taylor & Francis Medical Library - CRKN; Access via Taylor & Francis |
| subjects | Adult Anti-Anxiety Agents - adverse effects Anti-Anxiety Agents - therapeutic use Benzodiazepines Bromazepam compulsive Female Humans Male Middle Aged neurosis, obsessive Obsessive-Compulsive Disorder - drug therapy phobias Phobic Disorders - drug therapy Pyridines - adverse effects Pyridines - therapeutic use Substance Withdrawal Syndrome tranquillizing agents |
| title | Use of bromazepam in obsessional, phobic and related states |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T06%3A05%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-informahealthcare_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20bromazepam%20in%20obsessional,%20phobic%20and%20related%20states&rft.jtitle=Current%20medical%20research%20and%20opinion&rft.au=Burrell,%20R.%20H.&rft.date=1974&rft.volume=2&rft.issue=7&rft.spage=430&rft.epage=436&rft.pages=430-436&rft.issn=0300-7995&rft.eissn=1473-4877&rft_id=info:doi/10.1185/03007997409112660&rft_dat=%3Cinformahealthcare_cross%3E10_1185_03007997409112660%3C/informahealthcare_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/4156004&rfr_iscdi=true |